Auger-Architectomics: Introducing a New Nanotechnology to Infectious Disease
In 2010, we developed a new imaging nanotechnology called Auger-architectomics, to study drug biosensors in nano-detail. We succeeded in applying Auger atom electron physics coupled to scanning electron microscopy (SEM) and Argon-etching to cell structure exploration, thereby exposing a new dimension in structure and element composition architecture. Auger-architectomics was used to expose the fate and effect of drugs on cells. This technology should now be expanded to diseased cells. This paper will outline the development, proof of concept, and application of this imaging nanotechnology. A virtual tour is available at: http://vimeo.com/user6296337.
KeywordsAuger-architectomics Infectious disease Nanotechnology NanoSAM
The authors would like to thank The National Research Foundation (NRF) and The University of the Free State, South Africa, for financial support.
- 2.Kock JLF, Swart CW, Ncango DM, Kock Jr JLF, Munnik IA, Maartens MMJ, Pohl CH, Van Wyk PWJ (2009) Development of a yeast bio-assay to screen anti-mitochondrial drugs. Curr Drug Dev Tech 6(3):186–191Google Scholar
- 4.Davis HJ, Sebolai OM, Kock JLF, Lotter AP (2009) Use of non-steroidal anti-inflammatory drugs in the treatment of opportunistic infections. Patent application no. 2009/06259Google Scholar
- 5.Kock JLF, Swart CW, Ncango DM, Pohl CH (2011) Yeast “contraceptives” also novel drugs. http://obiocon.blogspot.com/2011/05/yeast-contraceptives-also-novel-drugs.html
- 6.Swart CW, Swart HC, Coetsee E, Pohl CH, Van Wyk PWJ, Kock JLF (2010) 3-D architecture and elemental composition of fluconazole treated yeast asci. Sci Res Essays 5(22):3411–3417Google Scholar
- 7.Kock JLF, Swart CW (2011) A new Nanotechnology for translational medicine. http://obiocon.blogspot.com/2011/03/new-nanotechnology-for-translational.html